(CTVA) Corteva - Ratings and Ratios
Seeds, Herbicides, Insecticides, Nitrogen Stabilizers, Digital
CTVA EPS (Earnings per Share)
CTVA Revenue
Description: CTVA Corteva
Corteva Inc (NYSE:CTVA) is a leading player in the agriculture industry, operating through two primary segments: Seed and Crop Protection. The company develops and supplies advanced germplasm and trait technologies that enhance crop yields and resistance to environmental stressors. Its digital solutions also enable farmers to optimize product selection and maximize profitability.
From a business perspective, Cortevas Seed segment is focused on producing high-quality seeds with desirable traits, while its Crop Protection segment offers a range of products that protect crops from pests, diseases, and weeds. The companys products and services are designed to enhance crop health and yields, and its global presence spans across the United States, Canada, Latin America, Asia Pacific, Europe, the Middle East, and Africa.
To evaluate Cortevas performance, key metrics to consider include revenue growth, gross margin ratio, and return on equity (ROE). With a current ROE of 4.65%, the company has room for improvement in terms of generating returns for shareholders. Additionally, its price-to-earnings (P/E) ratio of 45.08 and forward P/E of 26.81 suggest that the stock may be relatively expensive compared to its earnings. Other key performance indicators (KPIs) to monitor include the companys debt-to-equity ratio, interest coverage ratio, and crop protection product sales growth.
From a valuation perspective, Cortevas market capitalization stands at approximately $51 billion, indicating a significant presence in the agriculture industry. To further assess the companys value, it is essential to analyze its financial statements, including the income statement, balance sheet, and cash flow statement, to gain insights into its revenue streams, cost structure, and cash generation capabilities.
CTVA Stock Overview
| Market Cap in USD | 50,199m |
| Sub-Industry | Fertilizers & Agricultural Chemicals |
| IPO / Inception | 2019-05-24 |
CTVA Stock Ratings
| Growth Rating | 61.4% |
| Fundamental | 65.4% |
| Dividend Rating | 57.2% |
| Return 12m vs S&P 500 | 13.2% |
| Analyst Rating | 4.29 of 5 |
CTVA Dividends
| Dividend Yield 12m | 1.01% |
| Yield on Cost 5y | 2.52% |
| Annual Growth 5y | 4.88% |
| Payout Consistency | 100.0% |
| Payout Ratio | 21.8% |
CTVA Growth Ratios
| Growth Correlation 3m | -38.2% |
| Growth Correlation 12m | 84% |
| Growth Correlation 5y | 73.1% |
| CAGR 5y | 7.85% |
| CAGR/Max DD 3y | 0.23 |
| CAGR/Mean DD 3y | 0.60 |
| Sharpe Ratio 12m | 0.32 |
| Alpha | 18.09 |
| Beta | 0.775 |
| Volatility | 24.75% |
| Current Volume | 6555.4k |
| Average Volume 20d | 3242.8k |
| Stop Loss | 72 (-3.1%) |
| Signal | 0.96 |
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income (1.40b TTM) > 0 and > 6% of Revenue (6% = 1.03b TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 2.56pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 37.77% (prev 37.90%; Δ -0.13pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 3.14b > Net Income 1.40b (YES >=105%, WARN >=100%) |
| Net Debt (1.56b) to EBITDA (3.46b) ratio: 0.45 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.68 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (683.1m) change vs 12m ago -2.15% (target <= -2.0% for YES) |
| Gross Margin 45.65% (prev 43.91%; Δ 1.75pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 41.28% (prev 40.76%; Δ 0.52pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 10.55 (EBITDA TTM 3.46b / Interest Expense TTM 214.0m) >= 6 (WARN >= 3) |
Altman Z'' 1.43
| (A) 0.16 = (Total Current Assets 16.00b - Total Current Liabilities 9.52b) / Total Assets 41.76b |
| (B) 0.04 = Retained Earnings (Balance) 1.53b / Total Assets 41.76b |
| (C) 0.05 = EBIT TTM 2.26b / Avg Total Assets 41.61b |
| (D) -0.07 = Book Value of Equity -1.10b / Total Liabilities 15.61b |
| Total Rating: 1.43 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 65.42
| 1. Piotroski 8.50pt = 3.50 |
| 2. FCF Yield 5.02% = 2.51 |
| 3. FCF Margin 15.10% = 3.78 |
| 4. Debt/Equity 0.14 = 2.49 |
| 5. Debt/Ebitda 1.05 = 1.70 |
| 6. ROIC - WACC -3.02% = -3.77 |
| 7. RoE 5.68% = 0.47 |
| 8. Rev. Trend 26.56% = 1.33 |
| 9. Rev. CAGR 35.90% = 2.50 |
| 10. EPS Trend 36.46% = 0.91 |
| 11. EPS CAGR 0.0% = 0.0 |
What is the price of CTVA shares?
Over the past week, the price has changed by +2.75%, over one month by +4.84%, over three months by +2.69% and over the past year by +34.75%.
Is Corteva a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CTVA is around 74.32 USD . This means that CTVA is currently overvalued and has a potential downside of 0.04%.
Is CTVA a buy, sell or hold?
- Strong Buy: 13
- Buy: 5
- Hold: 6
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CTVA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 80.8 | 8.7% |
| Analysts Target Price | 80.8 | 8.7% |
| ValueRay Target Price | 82.8 | 11.4% |
Last update: 2025-09-04 04:35
CTVA Fundamental Data Overview
CCE Cash And Equivalents = 2.14b USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 34.0645
P/E Forward = 26.5252
P/S = 2.9225
P/B = 1.9446
P/EG = 2.1736
Beta = 0.746
Revenue TTM = 17.18b USD
EBIT TTM = 2.26b USD
EBITDA TTM = 3.46b USD
Long Term Debt = 1.69b USD (from longTermDebt, last quarter)
Short Term Debt = 1.94b USD (from shortTermDebt, last quarter)
Debt = 3.63b USD (Calculated: Short Term 1.94b + Long Term 1.69b)
Net Debt = 1.56b USD (from netDebt column, last quarter)
Enterprise Value = 51.69b USD (50.20b + Debt 3.63b - CCE 2.14b)
Interest Coverage Ratio = 10.55 (Ebit TTM 2.26b / Interest Expense TTM 214.0m)
FCF Yield = 5.02% (FCF TTM 2.59b / Enterprise Value 51.69b)
FCF Margin = 15.10% (FCF TTM 2.59b / Revenue TTM 17.18b)
Net Margin = 8.16% (Net Income TTM 1.40b / Revenue TTM 17.18b)
Gross Margin = 45.65% ((Revenue TTM 17.18b - Cost of Revenue TTM 9.34b) / Revenue TTM)
Tobins Q-Ratio = -46.78 (set to none) (Enterprise Value 51.69b / Book Value Of Equity -1.10b)
Interest Expense / Debt = 1.43% (Interest Expense 52.0m / Debt 3.63b)
Taxrate = 32.31% (412.0m / 1.27b)
NOPAT = 1.53b (EBIT 2.26b * (1 - 32.31%))
Current Ratio = 1.68 (Total Current Assets 16.00b / Total Current Liabilities 9.52b)
Debt / Equity = 0.14 (Debt 3.63b / last Quarter total Stockholder Equity 25.91b)
Debt / EBITDA = 1.05 (Net Debt 1.56b / EBITDA 3.46b)
Debt / FCF = 1.40 (Debt 3.63b / FCF TTM 2.59b)
Total Stockholder Equity = 24.68b (last 4 quarters mean)
RoA = 3.35% (Net Income 1.40b, Total Assets 41.76b )
RoE = 5.68% (Net Income TTM 1.40b / Total Stockholder Equity 24.68b)
RoCE = 8.56% (Ebit 2.26b / (Equity 24.68b + L.T.Debt 1.69b))
RoIC = 5.32% (NOPAT 1.53b / Invested Capital 28.71b)
WACC = 8.34% (E(50.20b)/V(53.83b) * Re(8.87%)) + (D(3.63b)/V(53.83b) * Rd(1.43%) * (1-Tc(0.32)))
Shares Correlation 3-Years: -99.24 | Cagr: -0.46%
Discount Rate = 8.87% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 66.80% ; FCFE base≈2.16b ; Y1≈1.42b ; Y5≈649.1m
Fair Price DCF = 16.42 (DCF Value 11.15b / Shares Outstanding 679.1m; 5y FCF grow -40.0% → 3.0% )
Revenue Correlation: 26.56 | Revenue CAGR: 35.90%
Rev Growth-of-Growth: 6.13
EPS Correlation: 36.46 | EPS CAGR: 0.0%
EPS Growth-of-Growth: 70.12
Additional Sources for CTVA Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle